Buspirone

Alternative Names: BuSpar

Buspirone is an anti-anxiety medication primarily used for generalized anxiety disorder (GAD). Unlike benzodiazepines, it does not cause sedation, dependence, or withdrawal symptoms, making it a safer long-term option. It works by modulating serotonin and dopamine receptors but may take 2–4 weeks to show full effect. It’s best for mild to moderate anxiety and is often used when patients cannot tolerate SSRIs or prefer a non-sedating option. Common side effects include dizziness, headache, and nausea.

Treatment Type: Prescription Medication

Treatment Class: Dopamine agonist

Treatment Modality: Oral

Review Summary

4.0

1 Reviews

Preferred by 1 Reviewers

Based on the review, Buspirone is considered a second-line treatment for generalized anxiety disorder with moderate effectiveness. It offers advantages like being non-sedating, non-addictive, and having fewer side effects compared to first-line treatments, but its overall efficacy is generally less robust than SSRIs. It is particularly useful for patients who cannot tolerate traditional antidepressants or are concerned about their side effects.

This summary was generated by users' reviews

Breakdown by Category

Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.

Cost
5.0
1 = Very Expensive 5 = Very Affordable

5.0

Very Affordable
Relief Speed
2.0
1 = No Relief 5 = Immediate Relief

2.0

Slow Relief
Side Effects
4.0
1 = Intolerable Effect 5 = No Effect

4.0

Mild Effect
Treatment Line
3.0
1 = Third-line or more 5 = First-line

3.0

Second Line

Explore various treatment options to empower yourself in making a well-informed choice.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

Choose treatments from the menu above to see how they compare side by side.

4.0

1 Reviews
5
0%
4
100%
3
0%
2
0%
1
0%

AI Summary of User Experiences

Not medical advice.

Based on the review, Buspirone is considered a second-line treatment for generalized anxiety disorder with moderate effectiveness. It offers advantages like being non-sedating, non-addictive, and having fewer side effects compared to first-line treatments, but its overall efficacy is generally less robust than SSRIs. It is particularly useful for patients who cannot tolerate traditional antidepressants or are concerned about their side effects.

Reviews

Filter by reviewer type Pro

Cost
Very Expensive
$1000+
Expensive
$501 to $1000
Moderate Cost
$101 to $500
Affordable
$25 to $100
Very Affordable
$25
Relief Speed
No Relief
No noticeable improvement
Slow Relief
Several days to weeks
Moderate Relief
Within 1 - 3 days
Fast Relief
Within hours
Immediate Relief
Within minutes
Side Effect
Intolerable Side Effect
Caused treatment to stop or required hospitalization
Severe Side Effect
Difficult to tolerate, may require intervention
Moderate Side Effect
Noticeable, but manageable
Mild Side Effect
Minor, not bothersome
No Side Effect
Without any adverse effects
Treatment Line
Third-line or more
Used after second-line failed or multiple prior treatment
Second-line
Used after first-line treatment failed or was unsuitable
First-line
First treatment tried
Dr. Curbside

Dr. Curbside

Verified
Physician • Emergency Medicine • How doctors think about decisions — and what real-world experiences add
2 months ago
Buspirone is an option for anxiety that I often consider when patients want to avoid some of the downsides of other medications. It doesn’t cause sedation, sexual side effects, or dependence, which makes it appealing compared with benzodiazepines or sometimes even SSRIs. It tends to work best for generalized anxiety and builds effect gradually over a few weeks. It may not be quite as strong as SSRIs for severe anxiety, but it’s usually well tolerated and a reasonable long-term option for many patients.
#VeryAffordable #CoveredByInsurance #SlowRelief #MildEffect #Second-line #Maintenance